Latest Strategic Growth News

Regis Resources reported a solid September quarter with 90.4koz gold production and a $158 million increase in cash and bullion. Key underground projects at Garden Well Main and Rosemont Stage 3 began ore production, supporting steady FY26 guidance.

Solis Minerals has raised $5.9 million to fund the acquisition and exploration of its promising Cucho copper project, alongside ongoing and upcoming drilling programs at Ilo Este and Cinto in Peru.

Tasman Resources has raised $2 million through a two-tranche placement to fund a promising drilling campaign at Parkinson Dam and broaden its project portfolio, alongside appointing a new director to steer its strategic ambitions.

Judo Capital Holdings Limited reported strong FY25 results with significant lending growth and profit increases, while expanding its SME banking footprint and advancing technology. The bank sets confident FY26 guidance amid strategic board changes.

South32 reported a robust September quarter with a 12% rise in copper equivalent production and a 33% surge in manganese volumes, while advancing key projects and maintaining full-year guidance.

Collins Foods unveiled ambitious growth plans at its 2025 Investor Day, spotlighting rapid expansion in Germany and operational enhancements in Australia and Europe. The company reaffirmed its FY26 profit growth targets, underpinned by digital innovation and brand modernization.

Genetic Signatures Ltd reports a robust start to FY2026 with a 20% quarterly sales increase, driven by new US contracts and strong growth in EMEA and Australia. The company also bolsters its leadership with a new CTO appointment.

EV Resources has secured a 150-tonne-per-day processing plant near its Los Lirios project, fast-tracking antimony production and positioning itself as a key North American supplier.

True North Copper has appointed Andrew Mooney as Managing Director, signaling a strategic shift towards advanced exploration and project development in Queensland.

Love Group Global Ltd reports a modest rise in quarterly cash receipts and operating cash flow, driven by a rebound in Hong Kong, while Singapore lags. The company signals early moves toward US and UK expansion.

Orthocell has boosted its investment in Marine Biomedical to secure exclusive global distribution rights for PearlBone™, an innovative bone substitute nearing FDA approval, enhancing its regenerative medicine portfolio.

AML3D has landed a $4.5 million contract to supply two custom ARCEMY metal 3D printing systems to Newport News Shipbuilding, marking a significant expansion in the US defense manufacturing sector.